Mounjaro and Zepbound generated a combined $11.7 billion in sales for the company in its most recent quarter.

Lilly agrees to acquire Orna Therapeutics in an all-cash deal.

Novo Nordisk just did Eli Lilly stock a huge favor.

Eli Lilly to buy Orna Therapeutics, which focuses on ‘in vivo’ CAR-T for autoimmune diseases, for $2.4 billion ...

Eli Lilly's full-year guidance comes in stark contrast to the outlook of Novo Nordisk, which warned it sees sales and profit ...

The rally in Lilly also pressured shares of its main weight-loss rival, Danish drugmaker Novo Nordisk ( NVO ), for a second ...

The plant will help make Lilly's experimental drug called retatrutide, which has shown the highest weight loss seen to date in a late-stage trial.

Eli Lilly reported higher fourth-quarter profit on the back of surging demand for its GLP-1 weight-loss drugs.